The Experts below are selected from a list of 270 Experts worldwide ranked by ideXlab platform
Sapan S. Desai - One of the best experts on this subject based on the ideXlab platform.
-
Variability in the Management of Superficial Venous Thrombophlebitis across Practitioners Based in North America and the Global Community
Thrombosis, 2014Co-Authors: Anahita Dua, Jennifer Heller, Bhavin Patel, Sapan S. DesaiAbstract:Introduction. This study aimed to compare management patterns of patients with SVT among healthcare practitioners based in North America versus those in the global community. Methods. A 17-question, multiple choice survey with questions regarding SVT diagnosis and management strategies was provided to practitioners who attended the American Venous Forum (AVF) meeting in 2011. Results. There were 487 practitioners surveyed with 365 classified as North American (US or Canada) and 122 (56 Europe, 25 Asia, 11 South America, and 7 Africa) representing the global community. The key difference seen between the groups was in the initial imaging study used in patients presenting with SVT () and physicians in the US ordered fewer bilateral duplex ultrasounds and more unilateral duplex ultrasounds (49.6% versus 58.2%, 39.7% versus 34.4%). In the US cohort, Phlebologists and vascular surgeons constituted 82% () of the specialties surveyed. In the global community, SVT was managed by Phlebologists or vascular surgeons 44% () of the time. Surgical management was highly variable between groups. Conclusion. There is currently no consensus between or among practitioners in North America or globally as to the surgical management of SVT, duration of follow-up, and anticoagulation parameters.
-
Variability in the Management of Superficial Venous Thrombophlebitis Among Phlebologists and Vascular Surgeons
Perspectives in vascular surgery and endovascular therapy, 2013Co-Authors: Anahita Dua, Jennifer Heller, Bhavin Patel, Sreyram Kuy, Joseph J. Dubose, Jeffrey S. Tomasek, Eric Mowatt Larssen, Sapan S. DesaiAbstract:Introduction This study aimed to compare management patterns of patients with superficial venous thrombophlebitis (SVT) among Phlebologists and vascular surgeons. Methods A survey was provided to practitioners who attended the American Venous Forum meeting in 2011. Statistical analysis included descriptive statistics, unpaired t tests, and Friedman's test for correlation. Results There were 354 US or Canadian health care providers of whom 169 were Phlebologists and 185 were vascular surgeons. There was a significant different in anticoagulation administration and duration (P = .034, P = .032, respectively). Friedman's test for correlation between multiple surgical treatments showed no correlation between surgical treatments tested with all treatments having an equal distribution in our data. Follow-up differed between groups with vascular surgeons following up with imaging more than Phlebologists (P = .03). Conclusion Our data indicate that there is no consensus between or among Phlebologists or vascular surgeons as to the surgical management of superficial venous thrombophlebitis, duration of follow-up, and anticoagulation parameters.
Anahita Dua - One of the best experts on this subject based on the ideXlab platform.
-
Variability in the Management of Superficial Venous Thrombophlebitis across Practitioners Based in North America and the Global Community
Thrombosis, 2014Co-Authors: Anahita Dua, Jennifer Heller, Bhavin Patel, Sapan S. DesaiAbstract:Introduction. This study aimed to compare management patterns of patients with SVT among healthcare practitioners based in North America versus those in the global community. Methods. A 17-question, multiple choice survey with questions regarding SVT diagnosis and management strategies was provided to practitioners who attended the American Venous Forum (AVF) meeting in 2011. Results. There were 487 practitioners surveyed with 365 classified as North American (US or Canada) and 122 (56 Europe, 25 Asia, 11 South America, and 7 Africa) representing the global community. The key difference seen between the groups was in the initial imaging study used in patients presenting with SVT () and physicians in the US ordered fewer bilateral duplex ultrasounds and more unilateral duplex ultrasounds (49.6% versus 58.2%, 39.7% versus 34.4%). In the US cohort, Phlebologists and vascular surgeons constituted 82% () of the specialties surveyed. In the global community, SVT was managed by Phlebologists or vascular surgeons 44% () of the time. Surgical management was highly variable between groups. Conclusion. There is currently no consensus between or among practitioners in North America or globally as to the surgical management of SVT, duration of follow-up, and anticoagulation parameters.
-
Variability in the Management of Superficial Venous Thrombophlebitis Among Phlebologists and Vascular Surgeons
Perspectives in vascular surgery and endovascular therapy, 2013Co-Authors: Anahita Dua, Jennifer Heller, Bhavin Patel, Sreyram Kuy, Joseph J. Dubose, Jeffrey S. Tomasek, Eric Mowatt Larssen, Sapan S. DesaiAbstract:Introduction This study aimed to compare management patterns of patients with superficial venous thrombophlebitis (SVT) among Phlebologists and vascular surgeons. Methods A survey was provided to practitioners who attended the American Venous Forum meeting in 2011. Statistical analysis included descriptive statistics, unpaired t tests, and Friedman's test for correlation. Results There were 354 US or Canadian health care providers of whom 169 were Phlebologists and 185 were vascular surgeons. There was a significant different in anticoagulation administration and duration (P = .034, P = .032, respectively). Friedman's test for correlation between multiple surgical treatments showed no correlation between surgical treatments tested with all treatments having an equal distribution in our data. Follow-up differed between groups with vascular surgeons following up with imaging more than Phlebologists (P = .03). Conclusion Our data indicate that there is no consensus between or among Phlebologists or vascular surgeons as to the surgical management of superficial venous thrombophlebitis, duration of follow-up, and anticoagulation parameters.
Markus Stuecker - One of the best experts on this subject based on the ideXlab platform.
-
Recurrence types 3 years after endovenous thermal ablation in insufficient saphenofemoral junctions.
Journal of vascular surgery. Venous and lymphatic disorders, 2020Co-Authors: Maria Zollmann, Christine Zollmann, Philipp Zollmann, Juergen Veltman, Philipp Cramer, Markus StueckerAbstract:Abstract Objective Although many studies have demonstrated that endovenous therapies have comparable efficacy to crossectomy and stripping, few studies have been published regarding the classification and recurrence patterns of varicose veins after endovenous therapy. This study attempted to provide an objective scheme for the definition and classification of recurrence. Moreover, it describes the types and rates of recurrence after endovenous thermal ablation, as well as factors associated with recurrence. Methods This prospective cohort study comprised a cohort of 449 patients with saphenofemoral junction (SFJ) insufficiency who underwent endoluminal varicose vein treatment for the first time in the limb between October 2013 and January 2015. The treatments were performed by a team of three experienced Phlebologists. For endovenous laser ablation, Biolitec ELVeS was used with bare, radial or radial slim fibers. Radiofrequency ablation was performed with VNUS ClosureFAST (Medtronic, Deggendorf, Germany). The patients were consecutively scheduled for 3-year follow-up examinations. Detailed ultrasound findings were collected by two experienced Phlebologists who classified the observed duplex ultrasound recurrence into different recurrence types. Results Clinically relevant recurrence was found in only 5.1% of cases. Examining only the recanalizations requiring reintervention resulted in a recurrence rate of 2.6%. However, if every new varicose vein that occurred postoperatively was considered a recurrence, the resultant recurrence rate was almost 54%. Preliminarily, we defined a recurrence as newly developed varicose veins within the region of the SFJ or along the course of the former treated vein distal to the SFJ. According to this definition, we obtained a clinically relevant recurrence rate of 5.3%, thus indicating that neovascular vessels were the largest recurrence type (57.7% within the region of the SFJ and 9.9% distal to the SFJ), followed by recanalization (8.9% within the region of the SFJ and 9.4% distal to the SFJ) and a refluxing anterior accessory saphenous vein (7.5%). We also developed a modified classification of progression to better understand recurrence after treatment of chronic venous insufficiency; the scheme included method failure (recanalization), neovascularizations, and disease progression (refluxing untreated vessels and new varicose veins occurring outside the treated region). The diameter of the treated vein (P = .001) and the clinical class according to CEAP classification (P = .008) were significant predictors of recurrence. Conclusions Endoluminal therapies are efficient methods for the treatment of varicose veins, which result in low recurrence rates after 3 years. Several factors influence the development of recurrence. This study provides a practice-oriented classification and description of recurrence with clinical relevance, through making distinctions among technical error, progression of the underlying disease and actual recurrence.
-
Practice patterns for prophylaxis and treatment of cancer related venous thromboembolism (VTE) in Germany: Comparison hematologists/oncologists (HOs) vs. angiologists/Phlebologists (APs).
Journal of Clinical Oncology, 2015Co-Authors: Axel Matzdorff, Markus Stuecker, Bettina Ledig, Hanno RiessAbstract:e20663 Background: VTE is a serious threat for cancer patients (pts). Guidelines recommend prophylactic education for all cancer patients about symptoms of VTE. Established VTE should be treated with low molecular weight heparin (LMWH) rather than vitamin K antagonists (VKAs) or any of the new direct oral anticoagulants (DOACs). We present a survey on the current approach to cancer related VTE in Germany by specialists and their adherence to guideline recommendations. Methods: A questionnaire on prophylaxis and treatment of cancer related VTE was sent to members of DGHO (German Society for Hematology and Oncology), BNHO (Professional Association of Hematologists and Oncologists in Private Practice) and DGP (German Society for Phlebology). Results: 214 HOs and 34 APs responded. 38% HOs and 70% APs routinely provide prophylactic education (p = 0.004) to pts. 33% HOs and 11% APs treat established VTE for max. 3 months (p = 0.024). For initial treatment (first 3-4 weeks) 79% HOs and 70% APs prescribe only LMW...
Jennifer Heller - One of the best experts on this subject based on the ideXlab platform.
-
Variability in the Management of Superficial Venous Thrombophlebitis across Practitioners Based in North America and the Global Community
Thrombosis, 2014Co-Authors: Anahita Dua, Jennifer Heller, Bhavin Patel, Sapan S. DesaiAbstract:Introduction. This study aimed to compare management patterns of patients with SVT among healthcare practitioners based in North America versus those in the global community. Methods. A 17-question, multiple choice survey with questions regarding SVT diagnosis and management strategies was provided to practitioners who attended the American Venous Forum (AVF) meeting in 2011. Results. There were 487 practitioners surveyed with 365 classified as North American (US or Canada) and 122 (56 Europe, 25 Asia, 11 South America, and 7 Africa) representing the global community. The key difference seen between the groups was in the initial imaging study used in patients presenting with SVT () and physicians in the US ordered fewer bilateral duplex ultrasounds and more unilateral duplex ultrasounds (49.6% versus 58.2%, 39.7% versus 34.4%). In the US cohort, Phlebologists and vascular surgeons constituted 82% () of the specialties surveyed. In the global community, SVT was managed by Phlebologists or vascular surgeons 44% () of the time. Surgical management was highly variable between groups. Conclusion. There is currently no consensus between or among practitioners in North America or globally as to the surgical management of SVT, duration of follow-up, and anticoagulation parameters.
-
Variability in the Management of Superficial Venous Thrombophlebitis Among Phlebologists and Vascular Surgeons
Perspectives in vascular surgery and endovascular therapy, 2013Co-Authors: Anahita Dua, Jennifer Heller, Bhavin Patel, Sreyram Kuy, Joseph J. Dubose, Jeffrey S. Tomasek, Eric Mowatt Larssen, Sapan S. DesaiAbstract:Introduction This study aimed to compare management patterns of patients with superficial venous thrombophlebitis (SVT) among Phlebologists and vascular surgeons. Methods A survey was provided to practitioners who attended the American Venous Forum meeting in 2011. Statistical analysis included descriptive statistics, unpaired t tests, and Friedman's test for correlation. Results There were 354 US or Canadian health care providers of whom 169 were Phlebologists and 185 were vascular surgeons. There was a significant different in anticoagulation administration and duration (P = .034, P = .032, respectively). Friedman's test for correlation between multiple surgical treatments showed no correlation between surgical treatments tested with all treatments having an equal distribution in our data. Follow-up differed between groups with vascular surgeons following up with imaging more than Phlebologists (P = .03). Conclusion Our data indicate that there is no consensus between or among Phlebologists or vascular surgeons as to the surgical management of superficial venous thrombophlebitis, duration of follow-up, and anticoagulation parameters.
Bhavin Patel - One of the best experts on this subject based on the ideXlab platform.
-
Variability in the Management of Superficial Venous Thrombophlebitis across Practitioners Based in North America and the Global Community
Thrombosis, 2014Co-Authors: Anahita Dua, Jennifer Heller, Bhavin Patel, Sapan S. DesaiAbstract:Introduction. This study aimed to compare management patterns of patients with SVT among healthcare practitioners based in North America versus those in the global community. Methods. A 17-question, multiple choice survey with questions regarding SVT diagnosis and management strategies was provided to practitioners who attended the American Venous Forum (AVF) meeting in 2011. Results. There were 487 practitioners surveyed with 365 classified as North American (US or Canada) and 122 (56 Europe, 25 Asia, 11 South America, and 7 Africa) representing the global community. The key difference seen between the groups was in the initial imaging study used in patients presenting with SVT () and physicians in the US ordered fewer bilateral duplex ultrasounds and more unilateral duplex ultrasounds (49.6% versus 58.2%, 39.7% versus 34.4%). In the US cohort, Phlebologists and vascular surgeons constituted 82% () of the specialties surveyed. In the global community, SVT was managed by Phlebologists or vascular surgeons 44% () of the time. Surgical management was highly variable between groups. Conclusion. There is currently no consensus between or among practitioners in North America or globally as to the surgical management of SVT, duration of follow-up, and anticoagulation parameters.
-
Variability in the Management of Superficial Venous Thrombophlebitis Among Phlebologists and Vascular Surgeons
Perspectives in vascular surgery and endovascular therapy, 2013Co-Authors: Anahita Dua, Jennifer Heller, Bhavin Patel, Sreyram Kuy, Joseph J. Dubose, Jeffrey S. Tomasek, Eric Mowatt Larssen, Sapan S. DesaiAbstract:Introduction This study aimed to compare management patterns of patients with superficial venous thrombophlebitis (SVT) among Phlebologists and vascular surgeons. Methods A survey was provided to practitioners who attended the American Venous Forum meeting in 2011. Statistical analysis included descriptive statistics, unpaired t tests, and Friedman's test for correlation. Results There were 354 US or Canadian health care providers of whom 169 were Phlebologists and 185 were vascular surgeons. There was a significant different in anticoagulation administration and duration (P = .034, P = .032, respectively). Friedman's test for correlation between multiple surgical treatments showed no correlation between surgical treatments tested with all treatments having an equal distribution in our data. Follow-up differed between groups with vascular surgeons following up with imaging more than Phlebologists (P = .03). Conclusion Our data indicate that there is no consensus between or among Phlebologists or vascular surgeons as to the surgical management of superficial venous thrombophlebitis, duration of follow-up, and anticoagulation parameters.